Fair Value Measurement (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Summary of Assets Measured at Fair Value |
The following tables provide a summary of the assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements as of September 30, 2026 | | (in thousands) | | Level 1 | | Level 2 | | Level 3 | | Total | | Cash equivalents: | | | | | | | | | | Money market funds | | $ | 16,073 | | | $ | — | | | $ | — | | | $ | 16,073 | | | | | | | | | | | | | | | | | | | | | Total cash equivalents | | $ | 16,073 | | | $ | — | | | $ | — | | | $ | 16,073 | | | | | | | | | | | | Short-term investments: | | | | | | | | | Government securities | | $ | 13,112 | | | $ | — | | | $ | — | | | $ | 13,112 | | | Corporate debt securities | | — | | | 17,466 | | | — | | | 17,466 | | | Commercial paper | | — | | | 10,749 | | | — | | | 10,749 | | | Total short-term investments | | $ | 13,112 | | | $ | 28,215 | | | $ | — | | | $ | 41,327 | | | | | | | | | | | | Liabilities: | | | | | | | | | | Current contingent liabilities | | $ | — | | | $ | — | | | $ | 793 | | | $ | 793 | | | Long-term contingent liabilities | | — | | | — | | | 219 | | | 219 | | | Total contingent liabilities | | $ | — | | | $ | — | | | $ | 1,012 | | | $ | 1,012 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements as of December 31, 2025 | | (in thousands) | | Level 1 | | Level 2 | | Level 3 | | Total | | Cash equivalents: | | | | | | | | | | Money market funds | | $ | 20,080 | | | $ | — | | | $ | — | | | $ | 20,080 | | | Total cash equivalents | | $ | 20,080 | | | $ | — | | | $ | — | | | $ | 20,080 | | | | | | | | | | | | Short-term investments: | | | | | | | | | | Government securities | | $ | 28,501 | | | $ | — | | | $ | — | | | $ | 28,501 | | | Total short-term investments | | $ | 28,501 | | | $ | — | | | $ | — | | | $ | 28,501 | | | | | | | | | | | | Liabilities: | | | | | | | | | | Current contingent liabilities | | $ | — | | | $ | — | | | $ | 1,044 | | | $ | 1,044 | | | Long-term contingent liabilities | | — | | | — | | | 315 | | | 315 | | | Total contingent liabilities | | $ | — | | | $ | — | | | $ | 1,359 | | | $ | 1,359 | |
|
| Summary of Liabilities Measured at Fair Value |
The following tables provide a summary of the assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements as of September 30, 2026 | | (in thousands) | | Level 1 | | Level 2 | | Level 3 | | Total | | Cash equivalents: | | | | | | | | | | Money market funds | | $ | 16,073 | | | $ | — | | | $ | — | | | $ | 16,073 | | | | | | | | | | | | | | | | | | | | | Total cash equivalents | | $ | 16,073 | | | $ | — | | | $ | — | | | $ | 16,073 | | | | | | | | | | | | Short-term investments: | | | | | | | | | Government securities | | $ | 13,112 | | | $ | — | | | $ | — | | | $ | 13,112 | | | Corporate debt securities | | — | | | 17,466 | | | — | | | 17,466 | | | Commercial paper | | — | | | 10,749 | | | — | | | 10,749 | | | Total short-term investments | | $ | 13,112 | | | $ | 28,215 | | | $ | — | | | $ | 41,327 | | | | | | | | | | | | Liabilities: | | | | | | | | | | Current contingent liabilities | | $ | — | | | $ | — | | | $ | 793 | | | $ | 793 | | | Long-term contingent liabilities | | — | | | — | | | 219 | | | 219 | | | Total contingent liabilities | | $ | — | | | $ | — | | | $ | 1,012 | | | $ | 1,012 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements as of December 31, 2025 | | (in thousands) | | Level 1 | | Level 2 | | Level 3 | | Total | | Cash equivalents: | | | | | | | | | | Money market funds | | $ | 20,080 | | | $ | — | | | $ | — | | | $ | 20,080 | | | Total cash equivalents | | $ | 20,080 | | | $ | — | | | $ | — | | | $ | 20,080 | | | | | | | | | | | | Short-term investments: | | | | | | | | | | Government securities | | $ | 28,501 | | | $ | — | | | $ | — | | | $ | 28,501 | | | Total short-term investments | | $ | 28,501 | | | $ | — | | | $ | — | | | $ | 28,501 | | | | | | | | | | | | Liabilities: | | | | | | | | | | Current contingent liabilities | | $ | — | | | $ | — | | | $ | 1,044 | | | $ | 1,044 | | | Long-term contingent liabilities | | — | | | — | | | 315 | | | 315 | | | Total contingent liabilities | | $ | — | | | $ | — | | | $ | 1,359 | | | $ | 1,359 | |
|
| Summary of Changes in the Fair Value of the Company's Level 3 Financial Instruments that are Measured at Fair Value |
A reconciliation of the Level 3 financial instruments as of September 30, 2026 and December 31, 2025 is as follows:
| | | | | | | | | | (in thousands) | | Icagen | Balance as of January 1, 2025 | | $ | 1,484 | | Payments of contingent liabilities | | (450) | | | Fair value adjustments to contingent liabilities | | 325 | | Balance as of December 31, 2025 | | $ | 1,359 | | Payments of contingent liabilities | | (263) | | | Fair value adjustments to contingent liabilities | | (84) | | Balance as of September 30, 2026 | | $ | 1,012 | |
|